Author(s): Musimbi A
Despite much progress in the management of malignant diseases, the number of new cases and cancer-related deaths continues to rise around the world. More than half of new cases occur in economically developing countries, where more than two thirds of cancer deaths are expected. However, implementation of all necessary steps to accomplish the dissemination of state-of-the-art prevention, diagnosis, and management will require increased allocation of resources, and, more importantly, harmonization of the efforts of hundreds of national and international public health agencies, policy-setting bodies, governments, pharmaceutical companies, and philanthropic organizations. More than 30% of the members of the American Society of Clinical Oncology (ASCO) reside and practice outside US borders, and more than half of attendees at all of the scientific congresses and symposia organized by ASCO are international. As cancer has become an increasingly global disease, ASCO has evolved as a global organization. The ASCO Board of Directors currently includes members from France, Brazil, and Canada. In 2013, the ASCO Board of Directors identified a number of strategic priorities for the future. Recognizing the importance of non-US members to the society, their first strategic priority was improving the society's service to non-US members and defining these members' identity in the international oncology community. This article reviews current ASCO activities in the international arena and its future plans in global oncology.
Referred From: https://pubmed.ncbi.nlm.nih.gov/26578614/
Author(s): American Cancer Society (2005). How is breast cancer found
Author(s): McGrath I
Author(s): Apffelstaedt JP
Author(s): Neondo Henry
Author(s): Muchiri M
Author(s): Anders CK, Hsu DS, Broadwater G, et al.
Author(s): American cancer society
Author(s): Canbulat N, Uzun O
Author(s): Akhtari-Zavare M, Hanafiah JM, Abdul MR, et al.
Author(s): Yarbrough SS, Braden CJ